T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
Cancer Cell - United States
doi 10.1016/j.ccell.2016.08.004
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2016
Authors
Publisher
Elsevier BV